Trademark: 79101488
Word
CELLTRION
Status Date
Wednesday, August 17, 2022
Registration Number
4169803
Registration Date
Tuesday, July 10, 2012
Filing Date
Friday, April 1, 2011
Published for Opposition
Tuesday, April 24, 2012
40 Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
5 [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
35 Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
44 [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]
42 Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ]
The mark consists in a figure of three green circles and the word "CELLTRION" in black, in which said three green circles have a thin-lined circle, a thick-lined circle and a solid circle.
Page 2, line 28 through 30, "medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others" should be deleted in class 42.
The color(s) black, green is/are claimed as a feature of the mark.
Oct 21, 2023
Change Of Name/Address Rec'd From Ib
Dec 2, 2022
Change Of Name/Address Rec'd From Ib
Aug 17, 2022
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Aug 17, 2022
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Aug 16, 2022
Case Assigned To Post Registration Paralegal
Mar 18, 2022
Teas Section 71 & 15 Received
Oct 5, 2021
Correction From The Ib Examined, No Action Is Needed
Sep 18, 2021
Change Of Name/Address Rec'd From Ib
Sep 10, 2021
Correction Transaction Received From Ib
Aug 6, 2021
Change Of Owner Received From Ib
Jul 10, 2021
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Jul 2, 2021
International Registration Renewed
Apr 30, 2021
New Representative At Ib Received
Apr 19, 2019
Partial Invalidation Processed By The Ib
Mar 23, 2019
Partial Invalidation Of Reg Ext Protection Sent To Ib
Mar 23, 2019
Invalidation Processed
Mar 20, 2019
Partial Invalidation Of Reg Ext Protection Created
Jul 20, 2018
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jul 20, 2018
Registered - Partial Sec 71 Accepted
Jul 18, 2018
Case Assigned To Post Registration Paralegal
Jun 21, 2018
Teas Section 71 Received
Jun 21, 2018
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 10, 2017
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 26, 2015
Change Of Name/Address Rec'd From Ib
Oct 11, 2013
Correction Under Section 7 ¿ Processed
Oct 11, 2013
Assigned To Paralegal
Oct 11, 2013
Limitation From The Ib Examined And Entered
Aug 30, 2013
Limitation Of Goods Received From Ib
Dec 2, 2012
Notification Processed By Ib
Nov 4, 2012
Final Decision Transaction Processed By Ib
Oct 16, 2012
Final Disposition Notice Sent To Ib
Oct 16, 2012
Final Disposition Processed
Oct 10, 2012
Final Disposition Notice Created, To Be Sent To Ib
Jul 10, 2012
Registered-Principal Register
Apr 24, 2012
Official Gazette Publication Confirmation E-Mailed
Apr 24, 2012
Published For Opposition
Apr 4, 2012
Notification Of Possible Opposition Sent To Ib
Apr 4, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 4, 2012
Notification Of Notice Of Publication E-Mailed
Mar 19, 2012
Law Office Publication Review Completed
Mar 19, 2012
Assigned To Lie
Mar 2, 2012
Approved For Pub - Principal Register
Mar 2, 2012
Examiner's Amendment Entered
Mar 2, 2012
Notification Of Examiners Amendment E-Mailed
Mar 2, 2012
Examiners Amendment E-Mailed
Mar 2, 2012
Examiners Amendment -Written
Dec 15, 2011
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 15, 2011
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 18, 2011
Refusal Processed By Ib
Sep 23, 2011
Non-Final Action Mailed - Refusal Sent To Ib
Sep 22, 2011
Refusal Processed By Mpu
Sep 22, 2011
Non-Final Action (Ib Refusal) Prepared For Review
Sep 21, 2011
Non-Final Action Written
Sep 13, 2011
Application Filing Receipt Mailed
Sep 9, 2011
Assigned To Examiner
Sep 9, 2011
New Application Office Supplied Data Entered
Sep 8, 2011
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
